Loading the list…

Atara Biotherapeutics, Inc. (ATRA)

Nasdaq · ATRA

connecting

$7.70−2.90%

Closing prices for 13 November 2026

Loading chart

Company valuation

The series is stated in the current share scale after splits; dividends are not included in the price

Volatility 90d

64.58%

Place in range

24.83%

$121M

Net income, last year

−$17M

Earnings per share

−$1.54

Revenue growth, year over year

−6.33%sector median 7.81%

Based on the last 12 months of reports, through 30 June 2026

The sector median covers every company in the sector on the US market, loss-making ones included.

How to read the figures

Market capitalisation is the value of all of a company's shares at the current price: the price of one share times the number of shares.
P/S (price / sales) is market capitalisation divided by revenue over 12 months: what the market pays for each unit of sales. Useful when there is no profit yet.
ROA (return on assets) is net income divided by total assets: how efficiently the company uses what it owns.
The current ratio is current assets divided by short-term liabilities: whether the company has enough cash and inventory to pay its nearest debts.
Revenue growth is the change in revenue over the last 12 months against the same period a year earlier.